Effect of cystamine and 5-methoxytryptamine on the course of experimental bacteriemia in irradiated mice.
Vejbora
O
O
Hanovcová
I
I
Volenec
K
K
Dostál
M
M
D008735:5-Methoxytryptamine / Q000627:therapeutic use*; D000818:Animals; D003538:Cystamine / Q000627:therapeutic use*; D004307:Dose-Response Relationship, Radiation; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination; D004927:Escherichia coli Infections / Q000188:drug therapy* / Q000276:immunology; D005260:Female; D007113:Immunity, Innate / Q000187:drug effects / Q000528:radiation effects; D051379:Mice; D008810:Mice, Inbred C57BL; D010101:Oxygen Consumption / Q000187:drug effects / Q000528:radiation effects; D011833:Radiation Injuries, Experimental / Q000150:complications / Q000276:immunology / Q000517:prevention & control*; D011837:Radiation-Protective Agents; D018805:Sepsis / Q000188:drug therapy* / Q000276:immunology; D013047:Specific Pathogen-Free Organisms; D013154:Spleen / Q000187:drug effects / Q000378:metabolism / Q000528:radiation effects; D013997:Time Factors; D014363:Tryptamines / Q000627:therapeutic use*; D014916:Whole-Body Irradiation
D011837:Radiation-Protective Agents; D014363:Tryptamines; D008735:5-Methoxytryptamine; D003538:Cystamine